Depression and anxiety in inflammatory bowel disease: epidemiology, mechanisms and treatment

Tania H. Bisgaard, Kristine H. Allin, Laurie Keefer, Ashwin N. Ananthakrishnan, Tine Jess*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

141 Citations (Scopus)


Inflammatory bowel disease (IBD), which includes Crohn's disease and ulcerative colitis, is a chronic, relapsing immune-mediated disease with a varying and sometimes severe disease course. IBD is often diagnosed in early adulthood and can lead to a substantial decline in quality of life. It has been suggested that patients with IBD are at increased risk of depression and anxiety, but it is still unclear to what extent these diseases co-occur and in what sequence they arise. This Review summarizes the literature on the degree of co-occurrence of IBD with depression and anxiety and the temporal relationship between these diseases. We also discuss the effect of psychological stress on the onset and course of IBD. In addition, we outline the possible mechanisms underlying the co-occurrence of IBD and depression and anxiety, which include changes in brain signalling and morphology, increases in peripheral and intracerebral pro-inflammatory cytokines, impairment of the nitric oxide pathway, changes in vagal nerve signalling, gut dysbiosis and genetics. Finally, we examine the possible effects of treatment of depression and anxiety on the risk and course of IBD, the influence of psychological interventions on IBD, and the effects of IBD treatment on psychiatric comorbidity.

Original languageEnglish
JournalNature reviews. Gastroenterology & hepatology
Issue number11
Pages (from-to)717-726
Number of pages10
Publication statusPublished - Nov 2022

Bibliographical note

© 2022. Springer Nature Limited.


Dive into the research topics of 'Depression and anxiety in inflammatory bowel disease: epidemiology, mechanisms and treatment'. Together they form a unique fingerprint.

Cite this